Actuate Therapeutics Raises $9.96 Million in Public Offering
PUBLIC · ACTUOct 28, 2026
Amount Raised
$9.96 Million
Round Type
Post-IPO Equity
Fort WorthHealthcareHealth Care
Investors
Newbridge Securities Corporation
Description
Actuate Therapeutics, Inc. successfully closed a public offering, raising approximately $9.96 million. The offering involved the sale of 30,985,900 shares of common stock and related warrants. The proceeds will support the company's ongoing development efforts.
Who to call at Actuate Therapeutics, and when
A new round usually means Actuate Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Actuate Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Actuate Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Actuate Therapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Actuate Therapeutics
Location
1751 RIVER RUN
Fort Worth, Texas, United States
About
Actuate Therapeutics, Inc. (NASDAQ: ACTU) is a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers. Actuate’s lead investigational drug product, elraglusib (a novel GSK-3β inhibitor), targets molecular pathways in cancer that are involved in promoting tumor growth and resistance to conventional cancer drugs such as chemotherapy including several DNA Damage Response (DDR) pathways. Elraglusib is designed to act as a mediator of anti-tumor immunity through the inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) and regulates multiple immune checkpoints and immune cell function.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Actuate Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.